vs
Alkermes plc.（ALKS）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是世纪互联的1.1倍（$384.5M vs $362.7M），Alkermes plc.净利率更高（12.8% vs -10.7%，领先23.5%），Alkermes plc.自由现金流更多（$170.0M vs $-193.1M），过去两年世纪互联的营收复合增速更高（17.4% vs 4.8%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
ALKS vs VNET — 直观对比
营收规模更大
ALKS
是对方的1.1倍
$362.7M
净利率更高
ALKS
高出23.5%
-10.7%
自由现金流更多
ALKS
多$363.1M
$-193.1M
两年增速更快
VNET
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $362.7M |
| 净利润 | $49.3M | $-38.7M |
| 毛利率 | 88.0% | 20.9% |
| 营业利润率 | 15.1% | 0.5% |
| 净利率 | 12.8% | -10.7% |
| 营收同比 | -10.6% | — |
| 净利润同比 | -66.3% | — |
| 每股收益（稀释后） | $0.29 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSVNET
| Q4 25 | $384.5M | — | ||
| Q3 25 | $394.2M | $362.7M | ||
| Q2 25 | $390.7M | — | ||
| Q1 25 | $306.5M | $309.5M | ||
| Q4 24 | $430.0M | — | ||
| Q3 24 | $378.1M | $302.2M | ||
| Q2 24 | $399.1M | $274.4M | ||
| Q1 24 | $350.4M | $262.9M |
净利润ALKSVNET
| Q4 25 | $49.3M | — | ||
| Q3 25 | $82.8M | $-38.7M | ||
| Q2 25 | $87.1M | — | ||
| Q1 25 | $22.5M | $-2.4M | ||
| Q4 24 | $146.5M | — | ||
| Q3 24 | $92.4M | $-2.1M | ||
| Q2 24 | $91.4M | $-1.1M | ||
| Q1 24 | $36.8M | $-22.0M |
毛利率ALKSVNET
| Q4 25 | 88.0% | — | ||
| Q3 25 | 86.9% | 20.9% | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 83.9% | 25.2% | ||
| Q4 24 | 85.6% | — | ||
| Q3 24 | 83.3% | 23.2% | ||
| Q2 24 | 84.6% | 21.3% | ||
| Q1 24 | 83.3% | 21.6% |
营业利润率ALKSVNET
| Q4 25 | 15.1% | — | ||
| Q3 25 | 22.6% | 0.5% | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 4.5% | 0.1% | ||
| Q4 24 | 37.8% | — | ||
| Q3 24 | 27.7% | 24.5% | ||
| Q2 24 | 27.5% | 0.2% | ||
| Q1 24 | 12.4% | 0.2% |
净利率ALKSVNET
| Q4 25 | 12.8% | — | ||
| Q3 25 | 21.0% | -10.7% | ||
| Q2 25 | 22.3% | — | ||
| Q1 25 | 7.3% | -0.8% | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 24.4% | -0.7% | ||
| Q2 24 | 22.9% | -0.4% | ||
| Q1 24 | 10.5% | -8.4% |
每股收益（稀释后）ALKSVNET
| Q4 25 | $0.29 | — | ||
| Q3 25 | $0.49 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $0.88 | — | ||
| Q3 24 | $0.55 | — | ||
| Q2 24 | $0.53 | — | ||
| Q1 24 | $0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $890.8M |
| 总资产 | $2.5B | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALKSVNET
| Q4 25 | $388.6M | — | ||
| Q3 25 | $616.4M | $492.1M | ||
| Q2 25 | $521.2M | — | ||
| Q1 25 | $399.8M | $544.3M | ||
| Q4 24 | $291.1M | — | ||
| Q3 24 | $396.3M | $219.5M | ||
| Q2 24 | $535.1M | $247.2M | ||
| Q1 24 | $420.8M | $246.9M |
总债务ALKSVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALKSVNET
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | $890.8M | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | $927.8M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.3B | $902.9M | ||
| Q2 24 | $1.3B | $900.6M | ||
| Q1 24 | $1.3B | $895.1M |
总资产ALKSVNET
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $6.1B | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.1B | $5.4B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.2B | $4.3B | ||
| Q2 24 | $2.2B | $4.0B | ||
| Q1 24 | $2.1B | $3.9B |
负债/权益比ALKSVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $-193.1M |
| 自由现金流率自由现金流/营收 | 44.2% | -53.2% |
| 资本支出强度资本支出/营收 | 0.0% | 84.6% |
| 现金转化率经营现金流/净利润 | 3.45× | — |
| 过去12个月自由现金流最近4个季度 | $480.3M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流ALKSVNET
| Q4 25 | $170.1M | — | ||
| Q3 25 | $101.7M | $113.8M | ||
| Q2 25 | $150.2M | — | ||
| Q1 25 | $98.8M | $27.0M | ||
| Q4 24 | $190.4M | — | ||
| Q3 24 | $81.6M | $108.3M | ||
| Q2 24 | $146.0M | $55.8M | ||
| Q1 24 | $21.1M | $37.1M |
自由现金流ALKSVNET
| Q4 25 | $170.0M | — | ||
| Q3 25 | $84.4M | $-193.1M | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $88.7M | $-220.0M | ||
| Q4 24 | $180.6M | — | ||
| Q3 24 | $73.3M | $-95.0M | ||
| Q2 24 | $138.9M | $-81.6M | ||
| Q1 24 | $12.8M | $-102.2M |
自由现金流率ALKSVNET
| Q4 25 | 44.2% | — | ||
| Q3 25 | 21.4% | -53.2% | ||
| Q2 25 | 35.1% | — | ||
| Q1 25 | 28.9% | -71.1% | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 19.4% | -31.4% | ||
| Q2 24 | 34.8% | -29.8% | ||
| Q1 24 | 3.6% | -38.9% |
资本支出强度ALKSVNET
| Q4 25 | 0.0% | — | ||
| Q3 25 | 4.4% | 84.6% | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 3.3% | 79.8% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 2.2% | 67.3% | ||
| Q2 24 | 1.8% | 50.1% | ||
| Q1 24 | 2.4% | 53.0% |
现金转化率ALKSVNET
| Q4 25 | 3.45× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 4.40× | — | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 1.60× | — | ||
| Q1 24 | 0.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
VNET
暂无分部数据
